FUJIFILM Diosynth Biotechnologies Newsletter – January 2025

Latest News?

?

Celebrating the Opening of Our Latest Manufacturing Expansion??

We are pleased to announce the grand opening of our newly expanded production facility at the Hiller?d, Denmark campus. We have doubled our production capacity by adding six cutting-edge 20,000-liter mammalian cell culture bioreactors, underscoring our commitment to meeting the increasing global demand for essential therapies and setting the stage for the next expansion coming online in 2026.?

?

Expanding Our Global KojoX Manufacturing Network? ?

Our roadmap through 2028 will see us expand our existing manufacturing capabilities and capacities in Holly Springs, College Station, Billingham, Hiller?d and Toyama, replicating the same proven technology, facility designs, equipment, processes and procedures. We call this manufacturing ecosystem kojoX?. ? ? Every expansion we add to our network not only increases our global manufacturing capacity, but also provides quicker turnaround times and scalability – no matter the location.? ?

BioPharm International Spotlights Our Holly Springs Facility?

As the first phase of our Holly Springs, North Carolina site nears operational status, our collaboration with Jacobs Life Sciences Vice President and General Manager, Dana Tilley, alongside FUJIFILM Diosynth Biotechnologies' Vice President of Project Delivery, Jordan Ulrich, is featured in BioPharm International. ? ? Together, they discuss how modularization and digital delivery strategies are revolutionizing pharmaceutical manufacturing. Discover how this cutting-edge approach accelerates patient access to new and emerging treatments. ? ? Reflecting on a Collaborative Year with the Centre of Excellence in Bioprocessing? ?

We shared the highlights of the eventful year we have had collaborating with our partners at the Centre of Excellence in Bioprocessing in the UK. Our community’s efforts have resulted in impactful achievements, from enhancing research capabilities to fostering sustainable practices. These collaborations have not only strengthened our shared goals but have also driven positive changes within the industry.? ? ?

Thought Leadership??

?

Building a Global Network to Increase Speed and Reliable Supply of Biopharmaceuticals?

As global demand for life-saving medicines continues to rise, we are expanding our biomanufacturing network to boost production capacity and accelerate delivery, ensuring a reliable supply of essential therapies worldwide. Learn more about how we are advancing biomanufacturing by building an interconnected network of sites across key locations in the US, Europe, and Japan.?

?

Partnering Manufacturing Strategies & Facility Design For Patient-Centric Medicine Delivery?

Charlie Heise, Associate Director, Bioprocess Strategy and Development at FUJIFILM Diosynth Biotechnologies, delves into the importance of selecting the most suitable manufacturing strategy and how kojoX?, combined with our Apollo?X technology, can streamline the process from cell line development to commercial production at 20K L scale.?

?

Cell & Gene Outsourced Capacity Update?

This webinar offers a glimpse into the capacity expansion project at our Thousand Oaks, CA facility, and showcases examples of the flexibility and state-of-the-art designs to ensure that every Cell Therapy program, no matter where it is on the journey from discovery to marketing authorization, can be produced here.?

?

Large Molecule Capacity Update?

Rasmus Pedersen, Ph.D., Associate Director of Process Technology at FUJIFILM Diosynth Biotechnologies, outlines strategies to expand large-molecule production capacity to meet growing global medicine demand, noting the current gap that leaves 2 billion people without access.?

?

Upcoming Events?

?

Advanced Therapies Week 2025?

January 20-23, Dallas, TX?

?

Phacilitate's Advanced Therapies Week 2025 in Dallas is an excellent opportunity to connect with industry leaders and explore the future of advanced therapies. We invite you to reach out and schedule a meeting with our team through the event app, to discuss potential collaborations and explore how we can support your biopharmaceutical development needs.??

Outsourced Pharma Capacity Update Partner Week?

January 31, Online?

As part of Outsourced Pharma’s Capacity Update Partner Week, register to join FUJIFILM Diosynth Biotechnologies for a session on our Fill/Finish capabilities on January 31.?